NASDAQ:ONCY

Oncolytics Biotech Stock News

etoro logo Buy ONCY
*Your capital is at risk
$0.94
+0.0237 (+2.58%)
At Close: Jun 23, 2026
SAN DIEGO and CALGARY, AB , April 12, 2023 /PRNewswire/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC) today announced that Chief Medical Officer Thomas Heineman, M.D., Ph.D., will participat
Oncolytics Biotech Inc. (NASDAQ:ONCY ) Q4 2022 Earnings Conference Call March 3, 2023 8:30 AM ET Company Participants Jon Patton - Director, Investor Relations and Communications Matt Coffey - Chief E

New Strong Buy Stocks for January 18th

09:47am, Wednesday, 18'th Jan 2023
DTEGY, CYN, OKTA, HOWL and ONCY have been added to the Zacks Rank #1 (Strong Buy) List on January 18, 2022.

2 Sector ETFs Hovering Around a 52-Week High

02:18pm, Tuesday, 06'th Dec 2022
We all know that Wall Street is shattered this year. Still, two sectors -- Biotech and Aerospace -- have recently hit a 52-week high.
Does Oncolytics Biotech Inc. (ONCY) have what it takes to be a top stock pick for momentum investors? Let's find out.
Oncolytics Biotech (ONCY) receives a fast-track designation from the FDA for pelareorep combined with Roche's Tecentriq in advanced/metastatic pancreatic cancer indication.
Analysts say these are penny stocks to buy. Do you agree?
Oncolytics Biotech, Inc. (NASDAQ:ONCY ) Q3 2022 Earnings Conference Call November 7, 2022 8:30 AM ET Company Participants Jon Patton - Director, IR & Communication Matt Coffey - CEO Tom Heineman - CMO
Oncolytics Biotech Inc. (NASDAQ:ONCY ) Q2 2022 Results Conference Call August 11, 2022 8:30 AM ET Company Participants Jon Patton - Director of Investor Relations and Communications Matthew Coffey - P
Conference call and webcast to take place on Thursday, August 11, 2022, at 8:30 a.m. ET SAN DIEGO, CA and CALGARY, AB , July 27, 2022 /PRNewswire/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ON
Want to try an out-of-the-box approach? Tap Oncolytics Biotech (ONCY), Pediatrix Medical Group Inc (MD), Boot Barn (BOOT), Canada Goose (GOOS) and Leap Therapeutics (LPTX).
Oncolytics Biotech, Inc. (NASDAQ:ONCY ) Q1 2022 Earnings Conference Call May 5, 2022 5:00 PM ET Corporate Participants Jon Patton - Director, Investor Relations and Communications Matthew Coffey - Pre
SAN DIEGO, Calif. and CALGARY, AB , April 21, 2022 /PRNewswire/ -- Oncolytics Biotech ® Inc. (NASDAQ: ONCY) (TSX: ONC) today announced that Dr. Matt Coffey, President and Chief Executive Officer, wil
Oncolytics Biotech, Inc. (ONCY) CEO Matthew Coffey on Q4 2021 Results - Earnings Call Transcript

Oncolytics Biotech GAAP EPS of -C$0.14

09:10pm, Thursday, 03'rd Mar 2022 Seeking Alpha
Oncolytics Biotech press release (ONCY): Q4 GAAP EPS of -C$0.14.Net cash used in operating activities was C$22.4 million for the full year 2021, compared to C$22.1 million for the…
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE